APC to commercialize new bacterial strain for metabolic and mental health
date:Dec 21, 2020
e 2 diabetes, Dr. Harriet Schellekens, leader of the research and joint senior author of a study assessing the strains capabilities, tells.

The fact that it also reduces stress hormones corticosterone in mice and cortisol in (obese) humans is very exciting and suggest this strain may have applications to reduce stress.

She believes this warrants further investigation into B. longum APC1472 and its potential use as a psychobiotic to improve mental health. The strain could be developed as a su
2/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/24 19:24